BRAIN Biotech AG Revenue Growth & History (BNN)
BRAIN Biotech AG reported €49.6M in revenue for fiscal 2025, a decrease of 9.17% from the previous fiscal year.
View full BRAIN Biotech AG company overviewBRAIN Biotech AG annual revenue and growth
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €49.6M | −€5.0M | −9.17% |
| 2024 | 2024-09-30 | €54.6M | −€704,000 | −1.27% |
| 2023 | 2023-09-30 | €55.3M | €5.8M | +11.77% |
| 2022 | 2022-09-30 | €49.5M | €11.1M | +28.96% |
| 2021 | 2021-09-30 | €38.4M | €170,000 | +0.44% |
| 2020 | 2020-09-30 | €38.2M | −€340,000 | −0.88% |
| 2019 | 2019-09-30 | €38.6M | €11.5M | +42.55% |
| 2018 | 2018-09-30 | €27.1M | €3.0M | +12.24% |
| 2017 | 2017-09-30 | €24.1M | €1.3M | +5.75% |
| 2016 | 2016-09-30 | €22.8M | €18.9M | +482.86% |
| 2015 | 2015-09-30 | €3.9M | €870,000 | +28.62% |
| 2014 | 2014-09-30 | €3.0M | −€260,000 | −7.88% |
| 2013 | 2013-09-30 | €3.3M | €1.4M | +71.88% |
| 2012 | 2012-09-30 | €1.9M | −€1.9M | −49.47% |
| 2011 | 2011-09-30 | €3.8M | — | — |
BRAIN Biotech AG quarterly revenue
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | €11.2M | −€2.2M | −16.58% |
| Q2 2026 | 2026-03-31 | €11.5M | −€640,000 | −5.28% |
| Q1 2026 | 2025-12-31 | €11.9M | — | — |
| Q4 2025 | 2025-09-30 | €11.3M | — | — |
| Q3 2025 | 2025-06-30 | €13.5M | — | — |
| Q2 2025 | 2025-03-31 | €12.1M | — | — |
BRAIN Biotech AG revenue growth trends
Over the last five reported fiscal years, revenue grew from €38.2M to €49.6M, a compound annual growth rate of 5.36%. BRAIN Biotech AG's latest reported quarter, Q3 2026, generated €11.2M in revenue, a decrease of 16.58% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review BRAIN Biotech AG source filings ↗